• No results found

University of Groningen Non-cardiac comorbidities in heart failure with preserved ejection fraction Streng, Koen Wouter

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Non-cardiac comorbidities in heart failure with preserved ejection fraction Streng, Koen Wouter"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Non-cardiac comorbidities in heart failure with preserved ejection fraction

Streng, Koen Wouter

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2019

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Streng, K. W. (2019). Non-cardiac comorbidities in heart failure with preserved ejection fraction: Focussing

on obesity and renal dysfunction. University of Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Non-cardiac Comorbidities in Heart

Failure with Preserved Ejection

Fraction

Focussing on obesity and renal dysfunction

Koen W. Streng

(3)

The financial support of the Graduate School of Medical Sciences and the University of Groningen for the publication of this thesis is gratefully acknowledged.

Lay-out and printing by: Optima Grafische Communicatie ISBN: 978-94-6361-277-7

(4)

Non-cardiac Comorbidities in Heart Failure with Preserved Ejection Fraction Focussing on obesity and renal dysfunction

Proefschrift

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. E. Sterken en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op

woensdag 12 juni 2019 om 14.30 uur

door

Koen Wouter Streng geboren op 5 november 1988

te Apeldoorn

2

Non-cardiac Comorbidities in Heart

Failure with Preserved Ejection

Fraction

Focussing on obesity and renal dysfunction

Proefschrift

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. E. Sterken en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op woensdag 12 juni 2019 om 14.30 uur

door

Koen Wouter Streng

geboren op 5 november 1988 te Apeldoorn

(5)

Promotores Prof. dr. A.A. Voors Prof. dr. J.L. Hillege

Copromotor Dr. K. Damman

Beoordelingscommissie Prof. dr. M.C. Verhaar Prof. dr. R.A. de Boer Prof. dr. M.P. van den Berg

(6)

Paranimfen Mw. B.T. Santema Dhr. J.F. Nauta

Financial support by the Dutch Heart Foundation for the publication of this thesis is gratefully acknowledged. The research described in this thesis was supported by a grant of the Dutch Heart Foundation (2014B011 CVON RECONNECT)

(7)
(8)

Table of Contents

Chapter 1 Introduction 9

Chapter 2 Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction

19

Chapter 3 Associations of body mass index with laboratory and biomarkers in patients with acute heart failure

41

Circ Heart Fail 2017;10:e003350

Chapter 4 Waist-to-hip ratio and mortality in heart failure 67

Chapter 5 Clinical implications of low estimated protein intake in patients with heart failure

89

Submitted

Chapter 6 Renin-angiotensin system inhibition, worsening renal function, and outcome in heart failure patients with reduced and preserved ejection fraction: a meta-analysis of published study data

109

Circ Heart Fail 2017;10:e003588

Chapter 7 Urinary marker profiles in heart failure with reduced and preserved ejection fraction

133

To be submitted

Chapter 8 Summary and future perspectives 153

Appendices

Dutch summary | Nederlandse samenvatting 169 Acknowledgements | Dankwoord 177

Bibliography 183

(9)

Referenties

GERELATEERDE DOCUMENTEN

since patient characteristics in these groups are very different, and where there are treatment options available for reducing mortality and hospitalization in

comorbidities are more prevalent, are associated with a higher mortality risk and with more physical impairment in patients with heart failure with preserved ejection fraction

The study population consisted of 2033 patients originating from the PROTECT trial (a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist

A higher body mass index (BMI) is associated with better survival in heart failure (HF) patients, also known as the obesity paradox.. However, BMI does not account for body

We studied the prevalence, predictors and clinical outcome of estimated protein intake in 2516 patients from the BIOlogy Study to TAilored Treatment in Chronic Heart Failure

AIRE indicates Acute Infarction Ramipril Efficacy Study; ALOFT, Aliskiren Observation of Heart Failure Treatment; ARIANA-CHF-RD, Additive Renin Inhibition With Aliskiren on

In this study, and I believe it is for proper future research as well, I have firstly demonstrated that studying social dynamics of leadership with a fine lens should take

Bij een tekort aan energie in de pens (bij een rantsoen met uitsluitend graskuil als ruwvoer) kan het on- bestendig eiwit niet volledig worden omgezet in microbieel eiwit..